VIMAB Financial Statements From 2010 to 2024

VIMAB Stock   7.50  0.25  3.23%   
VIMAB Group financial statements provide useful quarterly and yearly information to potential VIMAB Group AB investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on VIMAB Group financial statements helps investors assess VIMAB Group's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting VIMAB Group's valuation are summarized below:
VIMAB Group AB does not now have any fundamental trend indicators for analysis.
Check VIMAB Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VIMAB Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . VIMAB financial statements analysis is a perfect complement when working with VIMAB Group Valuation or Volatility modules.
  
This module can also supplement various VIMAB Group Technical models . Check out the analysis of VIMAB Group Correlation against competitors.

VIMAB Group AB Company Return On Equity Analysis

VIMAB Group's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current VIMAB Group Return On Equity

    
  2.92  
Most of VIMAB Group's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VIMAB Group AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, VIMAB Group AB has a Return On Equity of 2.9153. This is much higher than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The return on equity for all Sweden stocks is notably lower than that of the firm.

VIMAB Group AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining VIMAB Group's current stock value. Our valuation model uses many indicators to compare VIMAB Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VIMAB Group competition to find correlations between indicators driving VIMAB Group's intrinsic value. More Info.
VIMAB Group AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VIMAB Group's earnings, one of the primary drivers of an investment's value.

About VIMAB Group Financial Statements

VIMAB Group shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although VIMAB Group investors may analyze each financial statement separately, they are all interrelated. The changes in VIMAB Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on VIMAB Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VIMAB Stock Analysis

When running VIMAB Group's price analysis, check to measure VIMAB Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIMAB Group is operating at the current time. Most of VIMAB Group's value examination focuses on studying past and present price action to predict the probability of VIMAB Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VIMAB Group's price. Additionally, you may evaluate how the addition of VIMAB Group to your portfolios can decrease your overall portfolio volatility.